12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Eliquis apixaban: Trial started

Boehringer said the Brigham and Women's Hospital began a 4-year, retrospective, U.S. study to analyze the use of oral anticoagulants from about 100,000 patients with non-valvular AF. The hospital will use claims data collected from insurer UnitedHealth Group (NYSE:UNH,...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >